Page 1 of Clinical Trials for ( Kadmon Corporation AND LLC ) [SPONSOR-COLLABORATORS], 6 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Completed
Safety and Pharmacokinetics of XL647 Administered Orally to Subjects With Solid Tumors
Last Updated: October 17, 2011
Condition(s): Cancer
2
Completed
Study of XL647 in Subjects With NSCLC Who Have Progressed After Responding to Treatment With Gefitinib or Erlotinib
Last Updated: January 24, 2012
Condition(s): Carcinoma, Non-Small-Cell Lung
3
Not yet recruiting
A Dose-Escalation Study of KD019 in Subjects With Autosomal Dominant Polycystic Kidney Disease
Last Updated: March 19, 2012
Condition(s): Polycystic Kidney, Autosomal Dominant
4
Completed
Study of XL647 Administered Orally Daily to Patients With Solid Tumors
Last Updated: October 17, 2011
Condition(s): Cancer
5
Recruiting
KD019 Versus Erlotinib in Subjects With Stage IIIB/IV Non Small Cell Lung Cancer With Progression After First- or Second-Line Chemotherapy
Last Updated: December 5, 2011
Condition(s): Carcinoma, Non-Small-Cell Lung
6
Completed
Study of XL647 in Subjects With Non-Small-Cell Lung Cancer
Last Updated: January 24, 2012
Condition(s): Non-small-cell Lung Cancer

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?spons=Kadmon+Corporation%2C+LLC

Page 1 of Clinical Trials for ( Kadmon Corporation AND LLC ) [SPONSOR-COLLABORATORS], 6 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About